Sriram Ryali does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Eiger BioPharmaceuticals, Inc., CODEXIS, INC., and Caribou Biosciences, Inc..

2021 was Sriram Ryali's most active year for acquiring shares with 4 total transactions. Sriram Ryali's most active month to acquire stocks was the month of February. 2022 was Sriram Ryali's most active year for disposing of shares, totalling 1 transactions. Sriram Ryali's most active month to dispose stocks was the month of February. 2025 saw Sriram Ryali paying a total of $24,651.20 for 317,360 shares, this is the most they've acquired in one year. In 2022 Sriram Ryali cashed out on 2,266 shares for a total of $12,683.48, their largest year based on trade value.